Literature DB >> 11302819

Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains.

M Tracy1, A Wanahita, Y Shuhatovich, E A Goldsmith, J E Clarridge, D M Musher.   

Abstract

Previous studies of the antibiotic susceptibility of Streptococcus milleri group organisms have distinguished among species by using phenotypic techniques. Using 44 isolates that were speciated by 16S rRNA gene sequencing, we studied the MICs and minimum bactericidal concentrations of penicillin, ampicillin, ceftriaxone, and clindamycin for Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus. None of the organisms was resistant to beta-lactam antibiotics, although a few isolates were intermediately resistant; one strain of S. anginosus was tolerant to ampicillin, and another was tolerant to ceftriaxone. Six isolates were resistant to clindamycin, with representation from each of the three species. Relatively small differences in antibiotic susceptibilities among species of the S. milleri group show that speciation is unlikely to be important in selecting an antibiotic to treat infection caused by one of these isolates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302819      PMCID: PMC90497          DOI: 10.1128/AAC.45.5.1511-1514.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Comparison of three methods for identification of Streptococcus milleri group isolates to species level.

Authors:  A Limia; T Alarcón; M L Jiménez; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-02       Impact factor: 3.267

2.  Species belonging to the "Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens.

Authors:  C Bantar; L Fernandez Canigia; S Relloso; A Lanza; H Bianchini; J Smayevsky
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

3.  Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus ("Streptococcus milleri group") are of different clinical importance and are not equally associated with abscess.

Authors:  J E Claridge; S Attorri; D M Musher; J Hebert; S Dunbar
Journal:  Clin Infect Dis       Date:  2001-04-20       Impact factor: 9.079

4.  Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group.

Authors:  J L Gómez-Garcés; J I Alós; R Cogollos
Journal:  Diagn Microbiol Infect Dis       Date:  1994-06       Impact factor: 2.803

5.  Rapid species identification of "Streptococcus milleri" strains by line blot hybridization: identification of a distinct 16S rRNA population closely related to Streptococcus constellatus.

Authors:  J A Jacobs; C S Schot; A E Bunschoten; L M Schouls
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

6.  Genotypic and phenotypic characterization of "Streptococcus milleri" group isolates from a Veterans Administration hospital population.

Authors:  J E Clarridge; C Osting; M Jalali; J Osborne; M Waddington
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

7.  In-vitro antimicrobial susceptibility of the "Streptococcus milleri' group (Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius).

Authors:  J A Jacobs; E E Stobberingh
Journal:  J Antimicrob Chemother       Date:  1996-02       Impact factor: 5.790

8.  Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius. Clinical relevance, hemolytic and serologic characteristics.

Authors:  J A Jacobs; H G Pietersen; E E Stobberingh; P B Soeters
Journal:  Am J Clin Pathol       Date:  1995-11       Impact factor: 2.493

9.  Testing of Streptococcus pneumoniae for resistance to penicillin.

Authors:  K J Marshall; D M Musher; D Watson; E O Mason
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

10.  Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus as distinct species.

Authors:  R A Whiley; D Beighton
Journal:  Int J Syst Bacteriol       Date:  1991-01
View more
  23 in total

1.  Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group.

Authors:  J A Jacobs; G J van Baar; N H London; J H Tjhie; L M Schouls; E E Stobberingh
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Identification of clinically relevant viridans group streptococci by sequence analysis of the 16S-23S ribosomal DNA spacer region.

Authors:  Chao Chien Chen; Lee Jene Teng; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

3.  Species-level molecular identification of invasive "Streptococcus milleri" group clinical isolates by nucleic acid sequencing in a centralized regional microbiology laboratory.

Authors:  Peter Daley; Deirdre L Church; Daniel B Gregson; Sameer Elsayed
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Periodontal bacteria in rabbit mandibular and maxillary abscesses.

Authors:  Kerin L Tyrrell; Diane M Citron; Jeffrey R Jenkins; Ellie J C Goldstein
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

5.  Pyogenic Pericarditis and Cardiac Tamponade Due to Streptococcus anginosus in a Combat Theater.

Authors:  Ryan C Maves; Michael S Tripp; Tracy Franzos; Scott C Wallace; Benjamin J Drinkwine; Todd C Villines
Journal:  Open Forum Infect Dis       Date:  2017-02-10       Impact factor: 3.835

6.  Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

7.  Mycotic Aneurysm Caused by Streptococcus constellatus subsp. constellatus.

Authors:  Wen-Chu Chiang; Jui-Chang Tsai; Shey-Ying Chen; Chiung-Yuan Hsu; Chen-Tu Wu; Lee-Jene Teng; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model.

Authors:  Andres F Zuluaga; Maria Agudelo; John J Cardeño; Carlos A Rodriguez; Omar Vesga
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

Review 9.  What happened to the streptococci: overview of taxonomic and nomenclature changes.

Authors:  Richard Facklam
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

10.  Streptococcus constellatus bacteremia causing septic shock following tooth extraction: a case report.

Authors:  Kay Wei Ping Ng; Amartya Mukhopadhyay
Journal:  Cases J       Date:  2009-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.